https://doi.org/10.1001/jamaoncol.2021.1683
N
Namrata Vijayvergia
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
2.2K
Citations
19
h-index
30
i10-index
Namrata Vijayvergia is an academic researcher from Fox Chase Cancer Center. The author has contributed to research in topics: Neuroendocrine Tumor Research Advances & Pancreatic and Hepatic Oncology Research & Lung Cancer Research Studies. The author has an h-index of 19, co-authored 99 publications.
ORCID: 0000-0001-6469-4759Papers by this author
worksUse of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
2021 · JAMA Oncology · 178 citations
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study
2016 · British Journal of Cancer · 112 citations
https://doi.org/10.1038/bjc.2016.229
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
2024 · New England Journal of Medicine · 111 citations
https://doi.org/10.1056/nejmoa2403991
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With <i>ERBB2/3</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
2024 · Journal of Clinical Oncology · 20 citations
https://doi.org/10.1200/jco.23.02078
TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial
2024 · British Journal of Cancer · 2 citations
https://doi.org/10.1038/s41416-024-02845-x
Racial/Ethnic Differences and Effects of Clinical/Socioeconomic Factors on Time from Diagnosis to Treatment in Pancreatic Cancer
2025 · Journal of Gastrointestinal Cancer · 1 citations
https://doi.org/10.1007/s12029-025-01188-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat